A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Liver Transplantation
Interventions
DRUG

Prograf

oral

DRUG

Advagraf

oral

DRUG

Myfortic

oral

Trial Locations (3)

Unknown

Taichung

Tainan City

Taipei

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Taiwan, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY